Intravesical gentamicin treatment for recurrent urinary tract infections caused by multidrug-resistant bacteria

In this study we aimed to assess the effectiveness, safety, and feasibility of prophylactic treatment with intravesical gentamicin in patients with refractory rUTI caused by multidrug-resistant (MDR) microorganisms.

Source: The Journal of Urology - October 11, 2018 Category: Urology & Nephrology Authors: Janneke E. Stalenhoef, Cees van Nieuwkoop, Petra H. Menken, Sandra T. Bernards, Henk W. Elzevier, Jaap T. van Dissel Source Type: research